| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,636 |
9,340 |
$656K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,711 |
11,550 |
$529K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,643 |
1,340 |
$130K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,422 |
4,298 |
$82K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,103 |
941 |
$80K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
973 |
862 |
$70K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,484 |
4,748 |
$66K |
| 99215 |
Prolong outpt/office vis |
695 |
600 |
$48K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,584 |
1,375 |
$48K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,803 |
1,728 |
$40K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
690 |
620 |
$39K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
494 |
451 |
$33K |
| 83037 |
|
3,908 |
3,200 |
$31K |
| 90674 |
|
1,410 |
1,203 |
$29K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,695 |
1,463 |
$24K |
| 3008F |
|
5,042 |
4,235 |
$18K |
| 81000 |
|
6,230 |
5,192 |
$17K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,010 |
1,744 |
$13K |
| 90686 |
|
1,882 |
1,683 |
$11K |
| 90715 |
|
509 |
400 |
$9K |
| 93000 |
|
550 |
453 |
$8K |
| 92553 |
|
425 |
385 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
197 |
185 |
$8K |
| 81025 |
|
1,507 |
1,270 |
$7K |
| 81002 |
|
4,511 |
3,839 |
$7K |
| 90732 |
|
77 |
68 |
$7K |
| 96127 |
|
2,166 |
1,903 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
253 |
229 |
$6K |
| 90677 |
|
32 |
30 |
$6K |
| 90716 |
|
199 |
177 |
$6K |
| 82044 |
|
1,203 |
999 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
3,839 |
3,286 |
$5K |
| 85018 |
|
2,201 |
1,957 |
$4K |
| 90756 |
|
218 |
194 |
$4K |
| 90734 |
|
389 |
351 |
$4K |
| 87430 |
|
355 |
310 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
213 |
176 |
$3K |
| 99441 |
|
276 |
244 |
$3K |
| 1159F |
|
1,210 |
985 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,098 |
994 |
$2K |
| 0011A |
|
84 |
50 |
$2K |
| 1160F |
|
1,138 |
973 |
$2K |
| 90651 |
|
559 |
508 |
$2K |
| 99177 |
|
448 |
409 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,951 |
1,707 |
$2K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
19 |
18 |
$2K |
| 3074F |
|
731 |
584 |
$2K |
| 90656 |
|
109 |
102 |
$2K |
| 0012A |
|
57 |
34 |
$2K |
| 3078F |
|
538 |
434 |
$2K |
| 92551 |
|
210 |
166 |
$2K |
| 99173 |
|
333 |
301 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
494 |
401 |
$1K |
| 90688 |
|
110 |
98 |
$1K |
| 92250 |
|
31 |
29 |
$1K |
| 3079F |
|
296 |
242 |
$1K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
33 |
23 |
$1K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
33 |
23 |
$848.84 |
| 82962 |
|
474 |
387 |
$842.77 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
86 |
67 |
$837.30 |
| 86769 |
|
23 |
22 |
$631.95 |
| 3044F |
|
760 |
575 |
$550.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$496.56 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
28 |
$422.68 |
| 3075F |
|
123 |
98 |
$420.00 |
| 0004A |
|
16 |
14 |
$416.80 |
| 96130 |
|
29 |
15 |
$400.00 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13 |
13 |
$365.50 |
| 90707 |
|
31 |
26 |
$355.30 |
| 1157F |
|
35 |
13 |
$350.00 |
| 99401 |
|
29 |
24 |
$303.08 |
| 90713 |
|
246 |
218 |
$290.41 |
| 96103 |
|
47 |
36 |
$284.26 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
69 |
57 |
$263.29 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
30 |
26 |
$232.12 |
| 90658 |
|
58 |
57 |
$229.08 |
| 90661 |
|
54 |
46 |
$210.00 |
| 3061F |
|
60 |
38 |
$170.00 |
| 2022F |
|
29 |
28 |
$110.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
36 |
29 |
$25.23 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
257 |
134 |
$9.49 |
| G0008 |
Administration of influenza virus vaccine |
102 |
93 |
$0.35 |
| 99000 |
|
550 |
491 |
$0.00 |
| 90619 |
|
21 |
20 |
$0.00 |
| 90744 |
|
17 |
15 |
$0.00 |
| 90633 |
|
185 |
167 |
$0.00 |
| 90714 |
|
43 |
39 |
$0.00 |
| 81003 |
|
13 |
12 |
$0.00 |